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Child health, infant formula 
funding and South African health 
professionals: Eliminating conflict  
of interest
To the Editor: Lake et al.[1] refer to the Allergy Society of South 
Africa (ALLSA) as an example of a professional body that may be 
fostering transgressions of regulation R991 (R991) of the Regulations 
Relating to Foodstuffs for Infants and Young Children.[2] They also 
infer that the low breastfeeding rate (BFR) in South Africa (SA) is a 
direct result of aggressive breastmilk substitute (BMS) marketing and 
transgressions of R991 and call for a total dissociation between BMS 
suppliers and healthcare professionals.
ALLSA actively encourages exclusive breastfeeding and supports all 
rational attempts to achieve it. The significant negative downstream 
health effects that BMSs (especially during the first 4 months of life) 
may have on immune dysregulation is a frequent discussion point in 
our journal and at our congresses.
However, ALLSA must also acknowledge that BMSs are necessary 
for some normal children whose mothers cannot breastfeed, and for 
children suffering from conditions where feeds of special medical 
composition are required. We are therefore concerned about some of 
the points that the authors raise (or fail to raise). We are particularly 
concerned about the manner in which the information regarding 
the cancelled BMS company-sponsored symposium at a recent 
ALLSA congress was obtained, and that the facts were not verified 
before publication. The advertisement (Fig. 1 in the article[1]) did 
not originate from ALLSA and was not approved or distributed 
by ALLSA. ALLSA also required confirmation from the BMS 
company involved regarding R991 adherence, and a legal opinion 
regarding compliance with the legislation was provided in writing. 
The conflicting interpretation of R991 by different legal advisers 
must therefore be questioned and should have been obtained prior 
to publication. ALLSA adheres to its position statement on BMS 
products and the Society’s relationship with suppliers.[3] An uncritical 
condemnation of all companies that manufacture and market BMS 
products is not supportable, as we have a role to play in guiding the 
appropriate use of BMS products.
A focus on other, and probably more important, reasons for failed 
breastfeeding will go further in advancing the BFR than a simple 
blanket condemnation of BMS products. In the SA private sector, 
up to 90% of women are delivered by caesarean section.[4] This 
proportion differs from that in other countries, and data implicate 
caesarean section delivery (especially scheduled caesarean section 
delivery) as a highly significant risk factor for failed breastfeeding.[5] 
Breastfeeding support is key to breastfeeding success.[6] The quality of 
support offered in public and private hospitals (as reflected by the low 
achievement of World Health Organization Baby-Friendly Hospital 
status) can be questioned. SA is a country of diversity, and differ ences 
in social, economic, perceptual and ethical reality may contribute 
to the low BFR. Is it fair to obstruct advice on BMS formulas in the 
face of hypoglycaemia or dehydration after elective caesarean section 
delivery and insufficient breastmilk production?
Quality research is needed into the true reasons for the low BFR in 
SA, and we should direct our energy towards addressing scientifically 
identified issues instead of simply pursuing a refusal of association 
with the BMS industry. ALLSA will continue to promote rigorous 
monitoring of R991.
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To the Editor: It is with concern that we took note of the article by 
Lake et al.,[1] in which there are numerous factual inaccuracies, gross 
generalisations and misleading statements. We address some of these 
below.
The article creates a negative image of the breastmilk substitutes 
industry in its totality without any nuances, substantiation or 
referencing of contraventions to the law.
‘Aggressive marketing’ is alleged without substantiation or by 
relating what is alleged to the 1939 and 1974 sources referred to.[2,3] 
The generalisation made is that these alleged contraventions cause 
conflict of interest among healthcare professionals and ultimately 
harm infants.
The law prohibits the promotion of designated products.[4,5] It 
does not prohibit technical and scientific communication between 
industry and healthcare professionals. The authors correctly state 
that Regulation 991 (R991) allows industry to participate in scientific 
meetings and pooled sponsorships, but fail to substantiate why 
exhibitions at conferences violate the law.
The authors quote exclusive breastfeeding rates, yet fail to add that 
the overall 6 months exclusive breastfeeding rate in South Africa (SA) 
increased from 7% in 1998 to 32% in 2016.[6]
The actual provisions of R991 are not referenced. The article leaves 
the reader with the impression that R991 contains provisions that it 
does not. R991 covers:
• labelling requirements (regulations 2 - 6)
• sale and promotion (regulation 7), but research grants and other 
financial support are allowed
• gift packs, samples and low-priced products are prohibited 
(regulations 8 - 9)
• display of designated products and educational material with a 
brand or company name or product description is prohibited 
(regulation 10)
• material directed at healthcare professionals is permitted 
(regulation 11).
In the concluding paragraph of their article,[1] the authors call for 
a total prohibition of sponsorship at academic meetings and a 
disclosure of funding sources. The latter is already in force, and 
sponsorship prohibition would require a legislative change.
The law allows for complaints and enforcement. It remains unclear 
whether the authors had indeed reported the alleged contraventions 
listed. The authors also claim unsubstantiated similar experiences 
at other universities. Also unsubstantiated is their statement that 
‘funding … has the potential to undermine health workers’ fiduciary 
duty to protect and promote child health’.
The Cochrane review[7] referred to by the authors relates to 
medicines and devices and concludes: ‘Sponsorship … by the 
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manufacturing company leads to more favorable efficacy results and 
conclusions than sponsorship by other source … industry bias … 
cannot be explained by standard “Risk of bias assessment”.’
As the Infant Feeding Association of South Africa (IFA), we agree 
with intensified efforts to promote breastfeeding. We also support 
vigorous monitoring of R991. However, the IFA warns against action 
that exceeds the ambit of the law or amounts to generalisations, and/
or unsubstantiated allegations.
The IFA has been and still is open to any constructive engagement 
in this field to ensure the best possible health outcome of infants in 
SA.
Naazneen Khan
On behalf of the Infant Feeding Association of South Africa
chair@ifa-sa.co.za
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Lake et al. respond: We thank Dr Van Niekerk and Ms Khan for their 
comments.
The reference to the Allergy Society of South Africa (ALLSA) 
conference in our article[1] was not intended as an attack on 
that organisation, but rather as an example of where industry 
attempted to contravene Regulation 991 (R991) at a health worker 
(HW) conference. Dr Van Niekerk questions whether marketing 
of breastmilk substitutes (BMSs) is a major reason for the low 
breastfeeding rate (BFR) in South Africa (SA), and states that we 
called for total dissociation of healthcare professionals from the BMS 
industry.
We agree that BMS marketing is not the only reason for the low 
BFR, and our abstract and first paragraph acknowledge that greater 
investment in promoting and supporting breastfeeding is required.[2] 
BMS marketing is, however, recognised as a major negative influence, 
hence our article’s focus.[3,4] A recent World Health Organization 
report concluded: ‘protecting the health of children and their mothers 
from continued misleading marketing practices should be seen by 
countries as a public health priority and human rights obligation’.[5] 
Recent decisions by international (Royal College of Paediatrics and 
Child Health, BMJ) and local organisations (South African Paediatric 
Association, University of Cape Town Department of Paediatrics and 
Child Health) no longer to accept funding from BMS companies 
acknowledge the need to protect mothers and HWs from BMS 
marketing.
The primary concern of BMS companies is profit, while HWs 
must promote health and development, and these divergent priorities 
lead to conflicts of interest.[6] We called on HWs to reconsider 
their relationships with industry and refuse all BMS funding – not 
dissociate totally, because (Dr van Niekerk is correct) BMSs are 
used, and HWs need to know their constituents, indications and 
evolu tion. R991 does not intend to limit counselling provided by 
independent HWs or women’s feeding choices. It aims to remove the 
influence of industry from these choices and counselling.
Ms Khan (an industry representative) alleges ‘factual inaccuracies, 
gross generalisations and misleading statements’ without identifying 
what these are. Fig. 1 in our article[1] details each contravention, 
referencing the actual R991 provision. For example, making specific 
nutritional or medicinal claims, or claims of a strong similarity 
between the product and breastmilk, is prohibited.
She is correct: exclusive breastfeeding in SA has improved – yet 
32% falls far short of the 2025 Global Nutrition Target of 50%.[7]
Despite R991[8] and the National Department of Health (NDoH) 
Guidelines to Industry and Health Care Personnel,[9] the BMS 
industry still finds ways to influence HW audiences. The Nestle 
Nutrition Institute advertised the cancelled breakfast symposium 
on breastmilk sugars and human milk oligosaccharides by email to 
delegates. Regulation 7(3) stipulates that industry is not allowed to 
provide ‘gifts’ in cash or kind to HWs. Meals and refreshments are 
specifically included in the definition of gift, so the NDoH deemed 
that the symposium contravened R991.
Much of Ms Khan’s response is based on what is legally required. 
Our argument is that HWs should practise what is best scientifically 
and ethically, not merely what is compliant with the law. This 
demands that every practitioner and organisation reflect on the 
determinants of poor breastfeeding practices and their own actions 
and activities that potentially undermine ideal behaviour.
Growth in formula milk sales is currently greatest in low- and 
middle-income countries.[3] A new Lancet Commission calls for 
stronger regulation to protect children from commercial marketing, 
including of formula milk.[10] Individuals, institutions and 
governments involved in child health (policy, research, training and 
service) need to act independently and with integrity in the best 
interests of children.
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